Pharmabiz2d
Trial to address disabling cognitive condition affecting stroke survivors to begin
Trial to address disabling cognitive condition affecting stroke survivors to begin: United Kingdom Thursday, October 31, 2024, 18:00 Hrs [IST] A major new trial will test the effi ...
Pharmabiz2d
WHO and partners activate Global Health Emergency Corps for the first time in response to mpox outbreak
Geneva, Switzerland Thursday, October 31, 2024, 17:00 Hrs [IST] ...
Pharmabiz2d
Ardena expands Bioanalytical Services in the Netherlands
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced a substantial expansion of ...
Pharmabiz2d
Valanx Biotech & FinaBio introduce ClickCRM for rapid conjugate vaccine development
Valanx Biotech & FinaBio introduce ClickCRM for rapid conjugate vaccine development: Klosterneuburg, Austria Thursday, October 31, 2024, 15:00 Hrs [IST] Valanx Biotech, a biotech ...
Pharmabiz2d
Protega Pharma receives US FDA approval for Roxybond IR 10 mg tablet with abuse-deterrent technology for management of pain
Princeton, New Jersey Thursday, October 31, 2024, 14:30 Hrs [IST] ...
Pharmabiz2d
Saol Therapeutics announces positive results from the SL-1002 RAISE Limb Spasticity Trial
Saol Therapeutics announces positive results from the SL-1002 RAISE Limb Spasticity Trial: Roswell, Georgia Thursday, October 31, 2024, 14:00 Hrs [IST] Saol Therapeutics, a privat ...
Pharmabiz2d
Owkin announces MSIntuit CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer
Owkin announces MSIntuit CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer: Paris Thursday, October 31, 2024, 13:00 Hr ...
Pharmabiz2d
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by US FDA
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by US FDA: Our Bureau, Bengaluru Thursday, October 31, 2024, 12:15 Hrs [IST] Biocon Biologics said its dr ...
Pharmabiz2d
US FDA grants accelerated approval to Novartis’ Scemblix for adult patients with newly diagnosed Ph+ CML-CP
US FDA grants accelerated approval to Novartis’ Scemblix for adult patients with newly diagnosed Ph+ CML-CP: East Hanover Thursday, October 31, 2024, 12:00 Hrs [IST] Novartis an ...
Pharmabiz2d
AJAX Engineering Charitable Trust with Doddaballapura General and Maternal &Child Hospital to enhance rural healthcare infrastructure
AJAX Engineering Charitable Trust with Doddaballapura General and Maternal &Child Hospital to enhance rural healthcare infrastructure: Our Bureau, Bengaluru Thursday, October 31, ...
Pharmabiz2d
Biocon Q2FY25 revenue at Rs. 3,623 crore, net loss at Rs. 16 crore
Biocon Q2FY25 revenue at Rs. 3,623 crore, net loss at Rs. 16 crore: Our Bureau, Bengaluru Thursday, October 31, 2024, 11:15 Hrs [IST] Biocon for the fiscal second quarter ended Se ...
Pharmabiz2d
WHO’s new report on tuberculosis shows approximately 8.2 million people were newly diagnosed with TB in 2023
WHO’s new report on tuberculosis shows approximately 8.2 million people were newly diagnosed with TB in 2023: Washington D.C Thursday, October 31, 2024, 11:00 Hrs [IST] The Worl ...